Breaking News

Aquestive Therapeutics Expands Libervant License/Supply Agreement with Pharmanovia

Agreement expands Libervant Buccal Film license to cover the rest of the world, excluding the U.S, Canada, and China.

Aquestive Therapeutics, a pharmaceutical company advancing medicines to improve current standards of care, has expanded its exclusive license and supply agreement with Atnahs Pharma UK Ltd., a global pharmaceutical company that works to extend and expand the lifecycle of established medicines, for Libervant (diazepam) Buccal Film to cover the rest of the world, excluding the U.S, Canada, and China. The original licensing agreement with Pharmanovia announced in Sept. 2022 covered the European ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters